Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Parisi

Showing results (41-50 of 130) with videos related to

Pageof 13
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 22, 2021
Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infectionIlaria Vicenti, Francesca Gatti, Renzo Scaggiante, et al.
Life (Basel, Switzerland)|September 28, 2021
BNT162b2 SARS-CoV-2 Vaccination Elicits High Titers of Neutralizing Antibodies to Both B.1 and P.1 Variants in Previously Infected and Uninfected SubjectsIlaria Vicenti, Francesca Gatti, Renzo Scaggiante, et al.
HIV Clinical Trials|August 9, 2013
Sustained virological response and baseline predictors in HIV-HCV coinfected patients retreated with pegylated interferon and ribavirin after failing a previous interferon-based therapy: systematic review and meta-analysisMonica Basso, Saverio Giuseppe Parisi, Carlo Mengoli, et al.
AIDS (London, England)|April 16, 2002
Human herpesvirus 8 cytoviraemia rebound in a patient with Kaposi's sarcoma after a short interruption of efficient antiretroviral therapySaverio Giuseppe Parisi, Romualdo Mazzi, Loredana Sarmati, et al.
Recenti Progressi in Medicina|October 30, 2023
[Making change: the new principles of the World organization of general medicine (Wonca 2022) and territorial medicine in Italy.]Viviana Forte, Rosario Falanga, Luigi Maria Bracchitta, et al.
Infection|August 3, 2021
The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjectsIlaria Vicenti, Francesca Gatti, Renzo Scaggiante, et al.
Jac-Antimicrobial Resistance|March 26, 2025
Distribution and prevalence of fungemia: a five-year retrospective multicentric survey in Venetian region, ItalyNicholas Geremia, Beatrice Bragato, Federico Giovagnorio, et al.
AIDS Research and Therapy|August 9, 2014
HCV RNA viral load is independent from CD4 cell count and plasma HIV RNA viral load in immunocompetent HIV-HCV co-infected patients: a 3-years follow-up studyMonica Basso, Marzia Franzetti, Renzo Scaggiante, et al.
Journal of Cardiovascular Development and Disease|April 15, 2020
Right Ventricular Function in Chronic Heart Failure: From the Diagnosis to the Therapeutic ApproachFrancesco Monitillo, Vito Di Terlizzi, Margherita Ilaria Gioia, et al.
Optics Express|January 29, 2025
Low complexity neural network equalizer for nonlinearity mitigation in digital subcarrier multiplexing systemsSasipim Srivallapanondh, Pedro Freire, Giuseppe Parisi, et al.
Pageof 13

Showing results (41-50 of 130) with videos related to

Sort By:
Pageof 13
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 22, 2021
Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infectionIlaria Vicenti, Francesca Gatti, Renzo Scaggiante, et al.
Life (Basel, Switzerland)|September 28, 2021
BNT162b2 SARS-CoV-2 Vaccination Elicits High Titers of Neutralizing Antibodies to Both B.1 and P.1 Variants in Previously Infected and Uninfected SubjectsIlaria Vicenti, Francesca Gatti, Renzo Scaggiante, et al.
HIV Clinical Trials|August 9, 2013
Sustained virological response and baseline predictors in HIV-HCV coinfected patients retreated with pegylated interferon and ribavirin after failing a previous interferon-based therapy: systematic review and meta-analysisMonica Basso, Saverio Giuseppe Parisi, Carlo Mengoli, et al.
AIDS (London, England)|April 16, 2002
Human herpesvirus 8 cytoviraemia rebound in a patient with Kaposi's sarcoma after a short interruption of efficient antiretroviral therapySaverio Giuseppe Parisi, Romualdo Mazzi, Loredana Sarmati, et al.
Recenti Progressi in Medicina|October 30, 2023
[Making change: the new principles of the World organization of general medicine (Wonca 2022) and territorial medicine in Italy.]Viviana Forte, Rosario Falanga, Luigi Maria Bracchitta, et al.
Infection|August 3, 2021
The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjectsIlaria Vicenti, Francesca Gatti, Renzo Scaggiante, et al.
Jac-Antimicrobial Resistance|March 26, 2025
Distribution and prevalence of fungemia: a five-year retrospective multicentric survey in Venetian region, ItalyNicholas Geremia, Beatrice Bragato, Federico Giovagnorio, et al.
AIDS Research and Therapy|August 9, 2014
HCV RNA viral load is independent from CD4 cell count and plasma HIV RNA viral load in immunocompetent HIV-HCV co-infected patients: a 3-years follow-up studyMonica Basso, Marzia Franzetti, Renzo Scaggiante, et al.
Journal of Cardiovascular Development and Disease|April 15, 2020
Right Ventricular Function in Chronic Heart Failure: From the Diagnosis to the Therapeutic ApproachFrancesco Monitillo, Vito Di Terlizzi, Margherita Ilaria Gioia, et al.
Optics Express|January 29, 2025
Low complexity neural network equalizer for nonlinearity mitigation in digital subcarrier multiplexing systemsSasipim Srivallapanondh, Pedro Freire, Giuseppe Parisi, et al.
Pageof 13